Biomea Fusion Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-127.27	-117.26	-81.83	-41.57	-5.32	-1.2
Depreciation & Amortization	4.72	4.2	1.26	0.95	0.13	0
Share-Based Compensation	15.92	14.13	10.34	6.23	0.32	0
Other Operating Activities	2.05	2.33	7.81	-1.06	0.41	-0.08
Operating Cash Flow	-104.58	-96.59	-62.42	-35.44	-4.46	-1.28
Capital Expenditures	-0.5	-3.37	-1.03	-3.17	-0.05	0
Change in Investments	0	1.15	28.37	-30.18	0	0
Investing Cash Flow	-0.5	-2.22	27.34	-33.36	-0.05	0
Share Issuance / Repurchase	163.71	163.8	1.24	153.22	10.19	1.44
Debt Issued / Paid	0	0	0	-0.04	0.04	0
Other Financing Activities	-	-	-	-	55.74	-
Financing Cash Flow	163.71	163.8	1.24	153.19	65.97	1.44
Net Cash Flow	58.64	64.99	-33.84	84.39	61.46	0.16
Free Cash Flow	-105.08	-99.96	-63.45	-38.61	-4.51	-1.28
Free Cash Flow Per Share	-2.93	-2.93	-2.17	-1.62	-0.43	-0.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).